Bioxodes is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of therapeutics for patients with thrombo-inflammatory diseases. We leverage our deep understanding of the thrombotic and inflammatory processes to design novel product candidates with an aim to address unmet medical needs.
Industry
Biotechnology, Scientific Research and Development Services, Services
HQ Location
Rue Santos-Dumont, 1
Brussels South Charleroi Biopark
Gosselies, Région Wallonne 6041, BE
Keywords
Hemorrhagic strokeIntracerebral hemorrhageAntithromboticCoagulation Factor XICoagulation Factor XIIThrombosisand Neuroinflammationpharmaceutical sciencesdiagnostic kitstechnological platforms